Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [ERYTHROKINETICS IN OSTEOMYELOFIBROSIS (STUDIES OF THE PRODUCTION AND DESTRUCTION OF ERYTHROCYTES WITH CR 51 FE 59)].

Literature DB >> 14231205

[ERYTHROKINETICS IN OSTEOMYELOFIBROSIS (STUDIES OF THE PRODUCTION AND DESTRUCTION OF ERYTHROCYTES WITH CR 51 FE 59)].

Abstract

Keywords: ANEMIA, APLASTIC; ANEMIA, HEMOLYTIC; CHROMIUM ISOTOPES; ERYTHROCYTES; ERYTHROPOIESIS; GERIATRICS; IRON ISOTOPES; IRON METABOLISM; MYELOFIBROSIS; PHYSIOLOGY; SPLEEN

Mesh：

Substances：

Year: 1964 PMID： 14231205 DOI： 10.1007/bf01484131

Source DB: PubMed Journal: Klin Wochenschr ISSN： 0023-2173

× No keyword cloud information.

22 in total

1. Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients.

Authors: B A BOURONCLE; C A DOAN
Journal: Am J Med Sci Date: 1962-06 Impact factor: 2.378

2. A simple method for the in vivo discrimination of chromium 51 and iron 59.

Authors: A CROOK; L SZUR
Journal: Br J Radiol Date: 1960-07 Impact factor: 3.039

3. [Splenectomy in myelosclerosis].

Authors: W Denef; P Desaive; G Leroux; H Betz; E Monnoyer
Journal: Acta Chir Belg Date: 1959-02 Impact factor: 1.090

4. Studies of the production and life span of erythrocytes in myeloid metaplasia.

Authors: D G NATHAN; N I BERLIN
Journal: Blood Date: 1959-06 Impact factor: 22.113

5. [On the clinical picture and pathology of osteomyelosclerosis].

Authors: G HARTMANN; R KLIMA; H CZITOBER; H RIEDER
Journal: Wien Z Inn Med Date: 1959-12

6. [Osteomyelosclerosis; report on 50 cases].

Authors: R KLIMA; J BEYREDER; H RIEDER
Journal: Wien Med Wochenschr Date: 1958-05-10

7. [Physiopathologic studies on myeloid splenomegaly with myelofibrosis; studies with radioactive iron and chromium].

Authors: L MEEUS-BITH; M BOIRON; C PAOLETTI; D CHRISTOL; M TUBIANA; J BOUSSER
Journal: Rev Hematol Date: 1957 Sep-Oct

8. Erythrokinetics: quantitative measurements of red cell production and destruction in normal subjects and patients with anemia.

Authors: E R GIBLETT; D H COLEMAN; G PIRZIOBIROLI; D M DONOHUE; A G MOTULSKY; C A FINCH
Journal: Blood Date: 1956-04 Impact factor: 22.113

9. The tagging of red cells and plasma proteins with radioactive chromium.

Authors: S J GRAY; K STERLING
Journal: J Clin Invest Date: 1950-12 Impact factor: 14.808

10. Radioactive sodium chromate for the study of survival of red blood cells. I. The effect of radioactive sodium chromate on red cells.

Authors: T F NECHELES; I M WEINSTEIN; G V LEROY
Journal: J Lab Clin Med Date: 1953-09

5 in total

[ERYTHROKINETICS IN OSTEOMYELOFIBROSIS (STUDIES OF THE PRODUCTION AND DESTRUCTION OF ERYTHROCYTES WITH CR 51 FE 59)].

1. Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients.

2. A simple method for the in vivo discrimination of chromium 51 and iron 59.

3. [Splenectomy in myelosclerosis].

4. Studies of the production and life span of erythrocytes in myeloid metaplasia.

5. [On the clinical picture and pathology of osteomyelosclerosis].

6. [Osteomyelosclerosis; report on 50 cases].

7. [Physiopathologic studies on myeloid splenomegaly with myelofibrosis; studies with radioactive iron and chromium].

8. Erythrokinetics: quantitative measurements of red cell production and destruction in normal subjects and patients with anemia.

9. The tagging of red cells and plasma proteins with radioactive chromium.

10. Radioactive sodium chromate for the study of survival of red blood cells. I. The effect of radioactive sodium chromate on red cells.

1. [Anemia in osteomyelosclerosis. Comparison between hematologic and erythrokinetic studies].

2. [Isotope studies in osteomyelofibrosis].

3. [On anemia in osteomyeloscleroses].

4. [Anemia and the total number of circulating erythrocytes in osteomyelosclerosis].

5. [Erythrokinetic studies in patients with metastasis of the bones].